Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00GIR
|
||||
| Former ID |
DIB015244
|
||||
| Drug Name |
DAC-060
|
||||
| Synonyms |
DAC-0060; DAC-60; HDAC inhibitor (topical, skin cancer/actinic keratosis), DAC
|
||||
| Indication | Keratosis [ICD10:L57.0] | Phase 2 | [1] | ||
| Company |
DAC Srl
|
||||
| Target and Pathway | |||||
| Target(s) | Histone deacetylase | Target Info | Inhibitor | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031213) | ||||
| REF 2 | Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed. Correction in: volume 4 on page 1369. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.